• CORNEIL 5 chứa Bisoprolol fumarat 5mg

    CORNEIL 5

    [pdf-embedder url="http://davipharm.info/wp-content/uploads/Toa-CORNEIL-TT-01_cv-5393e.2024.pdf"] 
  • CORNEIL-2.5_dieu_tri_ho_tro_suy_tim

    CORNEIL-2,5

    [pdf-embedder url="http://davipharm.info/wp-content/uploads/CORNEIL-25-0049.T2.pdf"] 
  • Dasarab_giam_nguy_co_tai _bien_tim_mach

    DASARAB

    [pdf-embedder url="http://davipharm.info/wp-content/uploads/DASARAB_06-DOT-162-2.pdf"]
  • TEGRUCIL-4

    Heart disease causing embolism: Prevention of thromboembolism complications caused by atrial fibrillation, mitral valve disease, artificial valve. Myocardial infarction: Prevention of thromboembolism complications in myocardial…
  • RAVENELL-62.5

    Treatment of pulmonary arterial hypertension (PAH) to improve exercise capacity and symptoms in patients with WHO functional class III. Efficacy has been shown in: •…
  • RAVENELL-125

    Treatment of pulmonary arterial hypertension (PAH) to improve exercise capacity and symptoms in patients with WHO functional class III. Efficacy has been shown in: •…
  • GON SA EZETI-10

    Primary Hypercholesterolaemia: Ezetimibe co-administered with an HMG-CoA reductase inhibitor (statin) is indicated as adjunctive therapy to diet for use in patients with primary (heterozygous familial…
  • GON SA ATZETI

    Therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due…
  • ESSEIL-5

    Cilnidipin is indicated for the treatment of hypertension. This is only the preview. Please check here for the full indication.
  • VASLOR-20

    Hypercholesterolaemia Atorvastatin is indicated as an adjunct to diet for reduction of elevated total cholesterol (total-C), LDL-cholesterol (LDL-C), apolipoprotein B, and triglycerides in adults, adolescents…
  • VASLOR-10

    Atorvastatin is indicated as an adjunct to diet for reduction of elevated total cholesterol (total-C), LDL-cholesterol (LDL-C), apolipoprotein B, and triglycerides in patients with primary…